phosphine has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azmanova, M; Cooper, PA; Pitto-Barry, A; Rafols, L; Seaton, CC; Shnyder, SD | 1 |
| Anjum, R; Cai, L; Clackson, T; Dalgarno, D; Dodd, R; Dwight, TA; Huang, WS; Jang, HG; Keats, J; Kohlmann, A; Li, F; Liu, S; Lu, X; Mohemmad, QK; Moran, LE; Narasimhan, NI; Ning, Y; Parillon, L; Qi, J; Rivera, VM; Romero, J; Shakespeare, WC; Thomas, M; Toms, A; Wang, F; Wang, Y; Wardwell, SD; Xu, Q; Xu, R; Xu, Y; Zhang, S; Zhou, T; Zhu, X; Zou, D | 1 |
2 other study(ies) available for phosphine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Anticancer Water-Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Coordination Complexes; Drug Screening Assays, Antitumor; Female; Humans; Ligands; Lung Neoplasms; Organophosphorus Compounds; Ovarian Neoplasms; Phosphines; Reactive Oxygen Species; Ruthenium; Water | 2022 |
Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase.
Topics: Administration, Oral; Anaplastic Lymphoma Kinase; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Female; Humans; Lung Neoplasms; Mice; Mice, SCID; Molecular Conformation; Neoplasms, Experimental; Organophosphorus Compounds; Phosphines; Protein Kinase Inhibitors; Pyrimidines; Rats; Receptor Protein-Tyrosine Kinases; Structure-Activity Relationship | 2016 |